Post-earnings recap
Reported
Thu, Jul 16, 2026
EPS actual
$6.38
EPS est.
$4.87
EPS surprise
+30.90%
1-day move
+1.16%
UnitedHealth Group reported a strong earnings per share, exceeding expectations significantly. The stock reacted positively, rising by 1.16%. However, without revenue figures or management commentary, it's challenging to assess the full impact of this quarter's performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $6.38 | N/A | +30.90% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.
UnitedHealth Group Incorporated (UNH) is a leading health care company that provides managed health care services. With a market cap of $359 billion, it plays a crucial role in the health care sector, impacting millions of lives through its insurance and health services.
Last quarter
In Q1-2026, UnitedHealth reported an EPS of $7.23, exceeding estimates by 11.66%. The stock reacted positively, gaining 6.96% the following day.
EPS beat streak
4Q
EPS beat rate
75%
Avg EPS surprise
+3.32%
Avg 1-day reaction
-6.87%
Investors are cautiously optimistic ahead of the earnings report, especially after a strong performance last quarter. However, there is uncertainty due to mixed historical results.
Bull case
If UnitedHealth continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially leading to a stock price increase.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price, reflecting concerns about future growth.
The print will turn on these.
Q1
What will the EPS be for this quarter, and how does it compare to analyst expectations?
Given the company's recent performance, a significant EPS figure could reinforce investor confidence or raise concerns if it falls short.
Q2
What guidance will management provide for the upcoming quarters?
Management's outlook will be critical for understanding future growth prospects and could influence stock performance significantly.
—
Est. EPS
$1.15
Est. Rev
$178M
Impl. Move
±7.1%
Why consensus could be wrong
The Street may be underestimating UnitedHealth's ability to maintain strong margins despite rising costs in the health care sector.
Supporting evidence
The company has a history of beating EPS estimates, with a 75% success rate over the last eight quarters.
Options pricing suggests a smaller move than historical averages, indicating potential for a surprise.
Recent performance trends indicate resilience in the face of economic pressures.
Key risk
If EPS exceeds $7.50, it could challenge the current cautious sentiment and lead to a reevaluation of growth prospects.
Pre-commit to what would confirm each case.
The market is weighing the potential for continued growth against the backdrop of recent mixed earnings results.
Bull confirmed if
An EPS of $7.50 or higher would confirm strong operational performance and support the bull case.
Bear confirmed if
An EPS below $6.50 would raise concerns about profitability and confirm the bear case.
What the market is pricing for the move.
Implied Move
±4.8%
Historical Avg
±9.7%
The options market is pricing in a moderate move of about 4.8%, indicating some uncertainty but not extreme volatility.
Options are pricing a smaller move compared to the historical average, suggesting potential for a larger reaction.
ATM IV
0.3%
30d HV
30.0%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options cheap in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
89.63%
of float
Insider
0.25%
of float
Holders
4,341
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
76,863,061 sh · $28.9B
8.56%
4.6%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If UnitedHealth beats expectations, history suggests a potential stock increase of around 3.1% on the following day, confirming positive momentum.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors await further commentary from management.
Miss
A miss could lead to a decline of approximately 14.9%, reflecting investor disappointment and concerns about future performance.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
8
2 buys·6 sells
Members
5
House + Senate
Est. Notional
$22,008.00–$155,000.00
disclosed dollar ranges
Most Active Members
3 trades
The lines on the call that would change the story.
Vanguard Capital Management LLC
59,311,525 sh · $22.3B
6.61%
0.8%
State Street Corporation
45,633,267 sh · $17.2B
5.08%
0.7%
Capital World Investors
29,887,932 sh · $11.2B
3.33%
7.6%
FMR, LLC
27,992,995 sh · $10.5B
3.12%
132.9%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Mixed
2 trades
Net selling
1 trade
Net selling
1 trade
Net selling
Recent Transactions
Traded Sep 24, 2026 · disclosed Oct 7, 2026
$1,001.00–$15,000.00
Traded Sep 10, 2026 · disclosed Sep 25, 2026
$15,001.00–$50,000.00
Traded Jul 30, 2026 · disclosed Aug 14, 2026
$1,001.00–$15,000.00
Traded Jul 10, 2026 · disclosed Jul 17, 2026
$1,001.00–$15,000.00
Traded Jun 12, 2026 · disclosed Jul 9, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.